Key players in the market are focused on product development and conducting preclinical and clinical trials to assess the efficacy of these products mainly through the safety profile offered by these therapies.
Key players operating in the development of B-cell maturation antigen (BCMA) targeted therapies market are Celgene Corporation, GlaxoSmithKline plc., Novartis AG, Juno Therapeutics, Gilead Sciences. Inc., Amgen Inc., Affimed N.V, Poseida Therapeutics, Inc., and Autolus Ltd.
B-cell Maturation Antigen (BCMA) Targeted Therapies Market Report Snapshots
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients